EMEA-002532-PIP01-18-M02

Key facts

Active substance
Phenobarbital
Therapeutic area
Neurology
Decision number
P/0301/2021
PIP number
EMEA-002532-PIP01-18-M02
Pharmaceutical form(s)
Oral suspension
Condition(s) / indication(s)
Treatment of epilepsy
Route(s) of administration
  • Oral use
  • Gastric use
Contact for public enquiries
Proveca Pharma Limited

simon@proveca.com

+44 (0)1614 682627

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating
Average
1 rating